Stocks · News reference
Kairos Pharma Partners With Bayer To Mull ENV-105 Inhibitor In Combination With Bayer’s XOFIGO
Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, today announced a strategic collaboration with Bayer to evaluate Kairos Pharma’s lead
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 22, 2026, 12:37 PM
- Checked
- Jul 22, 2026, 12:37 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Applied Optoelectronics, PDD Holdings And 3 Stocks To Watch Heading Into Monday
U.S. stock futures up, PDD, AAOI, and XPEV to report earnings, KAPA announces reverse stock split, GRRR expected to post earnings after close.
Read original at benzinga12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Picard Medical (AMEX:PMI) shares moved upwards by 34.6% to $4.32 during Monday's pre-market session. The company's market cap stands at $6.5 million. As per the press release, Q2 earnings came out 3
Read original at benzingaStock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Slip Ahead of Data-Heavy Week, Nvidia Earnings, and Jackson Hole—BABA, PMI, BIRK in Focus (UPDATED)
U.S. stock futures were mixed on Monday, as the Dow Jones index rose, the S&P 500 and Nasdaq 100 indices fell, after Friday's higher close.
Read original at benzinga